Comunicati Stampa
Scienza e Tecnologia

Mana.bio Unveils Mina™,The World's First Large Language Model-Powered AI Agent for Lipid Nanoparticles

Mina represents a breakthrough tool for scientists working in RNA delivery and therapeutics development. By providing access to curated data, predictive modeling, and optimized formulation insights, Mina accelerates the pace of discovery, reduces barriers to innovation, and enables researchers to pursue novel therapies with greater precision and confidence. Mina represents a breakthrough tool for scientists working in RNA delivery and therapeutics development. By providing access to curated...
BOSTON, (informazione.news - comunicati stampa - scienza e tecnologia)

Mina represents a breakthrough tool for scientists working in RNA delivery and therapeutics development. By providing access to curated data, predictive modeling, and optimized formulation insights, Mina accelerates the pace of discovery, reduces barriers to innovation, and enables researchers to pursue novel therapies with greater precision and confidence.

Mina, which is accessible at mina.mana.bio  is available to researchers and scientific professionals worldwide with select features designed to support experimentation, data analysis, and LNP design. Specifically, Mina offers:

While Mana.bio retains exclusive access to its most advanced predictive models and proprietary datasets, the company is committed to collaborating with partners interested in leveraging Mina's full platform capabilities.

Mana.bio is a biotechnology company pioneering AI-powered solutions for RNA therapeutics. With the world's largest curated LNP dataset and proprietary AI models, Mana.bio is accelerating the future of drug development and delivery to improve lives around the globe.

info@mana.bio  

Logo - https://mma.prnewswire.com/media/2576675/5510414/Manabio_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/manabio-unveils-minathe-worlds-first-large-language-model-powered-ai-agent-for-lipid-nanoparticles-302558318.html

Ufficio Stampa
 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
Allegati
Non disponibili